2014 - Distinguished Scientist Award, American Heart Association
2013 - Robert J. and Claire Pasarow Foundation Medical Research Award
2002 - Member of the National Academy of Sciences
The scientist’s investigation covers issues in Protein C, Thrombin, Thrombomodulin, Biochemistry and Immunology. His biological study spans a wide range of topics, including Tumor necrosis factor alpha, Endocrinology, Coagulation and Cell biology. His Thrombin research includes themes of Molecular biology, Fibrin, Binding site and Tissue factor.
His research on Thrombomodulin also deals with topics like
Charles T. Esmon mostly deals with Protein C, Thrombin, Thrombomodulin, Immunology and Biochemistry. Charles T. Esmon has researched Protein C in several fields, including Molecular biology, Receptor, Endothelial protein C receptor and Cell biology. His work carried out in the field of Thrombin brings together such families of science as Endocrinology, Antithrombin, Binding site and Tissue factor.
Blood proteins is closely connected to Protein S in his research, which is encompassed under the umbrella topic of Thrombomodulin. His study looks at the intersection of Immunology and topics like Pharmacology with Anticoagulant. His study in Biochemistry is interdisciplinary in nature, drawing from both Biophysics and Prothrombinase.
His primary areas of investigation include Immunology, Protein C, Inflammation, Cell biology and Endothelial protein C receptor. He interconnects Cancer research and Internal medicine, Endogeny, Coagulation in the investigation of issues within Immunology. His Protein C research is multidisciplinary, incorporating elements of Receptor, Thrombomodulin, Thrombin and Pharmacology.
His work focuses on many connections between Thrombomodulin and other disciplines, such as Fusion protein, that overlap with his field of interest in Tumor necrosis factor alpha. Charles T. Esmon combines subjects such as Reperfusion injury, Extracellular and Sepsis with his study of Inflammation. His Cell biology research is multidisciplinary, relying on both Endothelial stem cell, Molecular biology and Innate immune system.
The scientist’s investigation covers issues in Immunology, Inflammation, Protein C, Cell biology and Thrombomodulin. The study incorporates disciplines such as Necrosis and Cancer research in addition to Immunology. In Inflammation, he works on issues like Extracellular, which are connected to Histone.
The Protein C study combines topics in areas such as Endothelial stem cell, Molecular biology, Endothelial protein C receptor, Thrombin and In vivo. His Thrombin study integrates concerns from other disciplines, such as Receptor, Coagulation and Pharmacology. His studies deal with areas such as Randomized controlled trial and Fibrin as well as Thrombomodulin.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The roles of protein C and thrombomodulin in the regulation of blood coagulation.
Charles T. Esmon.
Journal of Biological Chemistry (1989)
Extracellular histones are major mediators of death in sepsis
Jun Xu;Xiaomei Zhang;Rosana Pelayo;Marc Monestier.
Nature Medicine (2009)
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.
F B Taylor;A Chang;C T Esmon;A D'Angelo.
Journal of Clinical Investigation (1987)
Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C
Charles T. Esmon;Whyte G. Owen.
Proceedings of the National Academy of Sciences of the United States of America (1981)
The interactions between inflammation and coagulation
Charles T. Esmon.
British Journal of Haematology (2005)
The Protein C Pathway
Charles T. Esmon.
Chest (2003)
Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C.
N L Esmon;W G Owen;C T Esmon.
Journal of Biological Chemistry (1982)
The regulation of natural anticoagulant pathways
Charles T. Esmon.
Science (1987)
FAMILIAL PROTEIN S DEFICIENCY IS ASSOCIATED WITH RECURRENT THROMBOSIS
R R Nixon;M R Cooper;C T Esmon.
Journal of Clinical Investigation (1984)
Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis
Saul N. Faust;Michael Levin;Odile B. Harrison;Robert D. Goldin.
The New England Journal of Medicine (2001)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation
Johannes Gutenberg University of Mainz
University of Michigan–Ann Arbor
Heidelberg University
Texas A&M University
Weizmann Institute of Science
University of Pennsylvania
Weizmann Institute of Science
University College London
University of Michigan
Alibaba Group (China)
Wuhan University
Duke University
Hasselt University
Monash University
United Arab Emirates University
Ehime University
Stanford University
Research Laboratory for Biotechnology and Biochemistry
GlaxoSmithKline (United Kingdom)
Tottori University
Hebrew University of Jerusalem
St Thomas' Hospital
University of Montreal
University of California, San Francisco